$77.44
+0.00 (+0.00%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
+5.30%
1Y
+33.45%
YTD
-2.09%
Open$78.36
Previous Close$77.44
Day High$78.79
Day Low$76.79
52W High$99.50
52W Low$40.00
Volume—
Avg Volume357.5K
Market Cap2.97B
P/E Ratio—
EPS$-6.57
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$78.91
Below
SMA 200
$68.08
Above
RSI (14)
34.9
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
19 analysts
Price Target
-71.0% upside
Current
$77.44
$77.44
Target
$22.47
$22.47
$15.33
$22.47 avg
$35.88
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 1.46B | 1.47B | 1.18B |
| Net Income | -261,677,643 | -297,076,371 | -250,070,353 |
| Profit Margin | -18.0% | -20.2% | -21.1% |
| EBITDA | -537,620,569 | -578,764,523 | -403,482,661 |
| Free Cash Flow | -321,004,356 | -279,609,663 | -183,137,834 |
| Rev Growth | +12.9% | +6.2% | -8.5% |
| Debt/Equity | 0.11 | 0.12 | 0.13 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $246.04 | +0.89% | 118.6 | 430.95B |
| AMGN | Amgen Inc | $410.95 | +1.51% | 25.1 | 219.39B |
| GILD | Gilead Sciences Inc | $133.21 | +1.80% | — | 165.85B |
| VRTX | Vertex Pharmaceuticals Inc | $496.07 | +2.49% | 28.3 | 124.51B |
| REGN | Regeneron Pharmaceuticals | $784.36 | +1.59% | 18.4 | 79.53B |
| ALNY | Alnylam Pharmaceuticals Inc | $219.20 | +1.43% | 35.2 | 28.41B |